These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658 [TBL] [Abstract][Full Text] [Related]
9. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain. Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model. Das A; Boyd N; Jones TR; Talarico N; McGuire PG Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589 [TBL] [Abstract][Full Text] [Related]
11. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119 [TBL] [Abstract][Full Text] [Related]
12. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. Eaton DL; Scott RW; Baker JB J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753 [TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator. Stump DC; Lijnen HR; Collen D J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the protease domain of urokinase-type plasminogen activator. Rockway TW; Nienaber V; Giranda VL Curr Pharm Des; 2002; 8(28):2541-58. PubMed ID: 12369939 [TBL] [Abstract][Full Text] [Related]
15. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wysocki AB; Kusakabe AO; Chang S; Tuan TL Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751 [TBL] [Abstract][Full Text] [Related]
16. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin. Scott RW; Eaton DL; Duran N; Baker JB J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496 [TBL] [Abstract][Full Text] [Related]
17. A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. Sanderson-Smith ML; Zhang Y; Ly D; Donahue D; Hollands A; Nizet V; Ranson M; Ploplis VA; Walker MJ; Castellino FJ PLoS Pathog; 2013; 9(7):e1003469. PubMed ID: 23853591 [TBL] [Abstract][Full Text] [Related]